Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(9):630-631; doi:10.1093/jnci/97.9.630
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Geipert, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geipert, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Vaccinating Men for HPV: New Strategy for Preventing Cervical Cancer In Women?

Nadja Geipert

The first 10% of the full text of this article appears below.

Several clinical trials are testing whether human papillomavirus (HPV) vaccines can ultimately be used to eradicate cervical cancer. Two of the more than 30 sexually transmitted HPV types, HPV-16 and HPV-18, cause more than 70% of the disease that kills 250,000 women worldwide each year.

But some researchers have focused their attention on HPV infection in men. These scientists consider the prevention of HPV infection in men as another way to eliminate cervical cancer . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?